1-6 of 6
Kirk Morris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3 -ITD AML: a randomized, placebo-controlled study by the ALLG

Clinical Trials & Observations
Sun Loo, Andrew W. Roberts, Natasha S. Anstee, Glen A. Kennedy, Simon He, Anthony P. Schwarer, Anoop K. Enjeti, James D’Rozario, Paula Marlton, Ian A. Bilmon, John Taper, Gavin Cull, Campbell Tiley, Emma Verner, Uwe Hahn, Devendra K. Hiwase, Harry J. Iland, Nick Murphy, Sundra Ramanathan, John Reynolds, Doen Ming Ong, Ing Soo Tiong, Meaghan Wall, Michael Murray, Tristan Rawling, Joanna Leadbetter, Leesa Rowley, Maya Latimer, Sam Yuen, Stephen B. Ting, Chun Yew Fong, Kirk Morris, Ashish Bajel, John F. Seymour, Mark J. Levis, Andrew H. Wei
Journal: Blood
Blood (2023) 142 (23): 1960–1971.
https://doi.org/10.1182/blood.2023020301
Published: 2023
Includes: Supplemental data
Journal Articles

High-Dose Cytarabine (HiDAC) Improves the Cure Rate of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Is It Better to be Given As Induction Therapy or As Consolidation Therapy?

Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Joel Wight, MBBS, Kathryn Jackson, MBBS, Ashanka Mahilal Beligaswatte, BA, MBBS, MD FRACP, FRCPA, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Glen Kennedy, MBBS, FRACP, FRCPA, Louisa Martin, MBBS, Ian D. Lewis, MBBS PhD FRACP FRCPA, Devendra Hiwase, MBBS, FRACP, FRCPA, MD PhD, Daniela Zantomio, FRACP, FRCPA, MBBS, Simon Z. He, MBBS,FRACP,FRCPA, Andrew Grigg, MBBS, MD FRACP, FRCPA, Kirk Morris, FRACP FRCPA MBBS, Peter Mollee, MBBS, MMedSc, FRACP, FRCPA, Paula Marlton, MBBS
Journal: Blood
Blood (2016) 128 (22): 3989.
https://doi.org/10.1182/blood.V128.22.3989.3989
Published: 2016
Journal Articles

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

Emad Uddin Abro, Kirk Morris, Georgina Hodges, Jason P Butler, Cameron Curley, Elango Subramonia Pillai, Glen A Kennedy
Journal: Blood
Blood (2013) 122 (21): 5017.
https://doi.org/10.1182/blood.V122.21.5017.5017
Published: 2013
Journal Articles

Results of a Prospective Phase II Randomized Study of Deferasirox (Exjade®) to Prevent Iatrogenic Iron Overload in Patients Undertaking Induction/Consolidation Chemotherapy for Acute Myeloid Leukaemia (HREC/10/QRBW/135)

Glen A Kennedy, MBBS FRACP FRCPA, Kirk Morris, MBBS FRACP FRCPA, Elango Pillai, MBBS FRACP FRCPA, Cameron Curley, MBBS FRACP FRCPA, Jason P. Butler, MBBS, FRACP, FRCPA, MMSc, Simon Durrant
Journal: Blood
Blood (2012) 120 (21): 3577.
https://doi.org/10.1182/blood.V120.21.3577.3577
Published: 2012
Journal Articles

Outcomes and Prognostic Factors for Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit

Kathryn A Jackson, MBBS(Hons), Peter Mollee, Kirk Morris, MBBS FRACP FRCPA, Dwane L Jackson, MBBS, Peter Kruger, Kerenaftali Klein, Glen A Kennedy, MBBS FRACP FRCPA
Journal: Blood
Blood (2012) 120 (21): 3613.
https://doi.org/10.1182/blood.V120.21.3613.3613
Published: 2012
Journal Articles

Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly Patients

Kathryn A Jackson, MBBS(Hon), Glen A Kennedy, MBBS FRACP FRCPA, Peter Mollee, Kirk Morris, MBBS FRACP FRCPA
Journal: Blood
Blood (2012) 120 (21): 4341.
https://doi.org/10.1182/blood.V120.21.4341.4341
Published: 2012